Trevi Therapeutics (NASDAQ:TRVI) Cut to “Sell” at Wall Street Zen
Wall Street Zen lowered shares of Trevi Therapeutics (NASDAQ:TRVI – Free Report) from a hold rating to a sell rating in a report published on Friday. Other analysts also recently issued reports about the stock. Raymond James upgraded shares of Trevi Therapeutics from an “outperform” rating to a “strong-buy” rating and lifted their price target […]
Wall Street Zen lowered shares of Trevi Therapeutics (NASDAQ:TRVI – Free Report) from a hold rating to a sell rating in a report published on Friday. Other analysts also recently issued reports about the stock. Raymond James upgraded shares of Trevi Therapeutics from an “outperform” rating to a “strong-buy” rating and lifted their price target […]
